incretin hormone glp-1 Incretin-based therapy of metabolic disease The biology of incretin hormones

The first oral candidate(s) could be approved on weight-loss efficacy below pens but with convenience and adherence upside

Lawsuits allege that Novo Nordisk failed to warn consumers of the dangers of blood clots

Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise

Enhancing Treatment Adherence Personalized support programs, digital tracking apps, and behavioral counseling could improve adherence

The Bottom Line GLP-1 medications like Ozempic and Wegovy have transformed the landscape of weight loss treatment

[DOI] [PubMed] [Google Scholar] 484.Fink R.I., Kolterman O.G., Griffin J., Olefsky J.M